MODIFIED RECOMBINANT FACTOR VIII AND VON WILLEBRAND FACTOR AND METHODS OF USE
The present invention provides novel methods of increasing the survival of a coagulation protein by inhibiting the interaction with a clearance receptor. The invention also provides methods of preparing compositions that inhibit coagulation protein clearance receptors. Conjugated coagulation proteins, including compositions and formulations thereof, are also provided by the present invention.
1 . A method of increasing the survival of a coagulation protein by inhibiting the interaction with a clearance receptor, the method comprising the steps of:
(a) modifying a coagulation protein with a water soluble polymer, and
(b) administering to a mammal in need thereof a therapeutically effective amount of a composition comprising the modified coagulation factor;
wherein the modification increases the survival of the protein in the Hood circulation of a mammal.
2 - 33 . (canceled)